Literature DB >> 11966947

Fatigue and psychological disorders in chronic hepatitis C.

Jennifer McDonald1, Jayasuriya Jayasuriya, Patricia Bindley, Craig Gonsalvez, Sonja Gluseska.   

Abstract

BACKGROUND AND AIM: Most patients with chronic hepatitis C report that they suffer from fatigue. The aim of this study was to determine if the symptom of fatigue can be a guide to indicate disease activity in chronic hepatitis C, or if it is related to psychological factors.
METHODS: 115 chronic hepatitis C patients attending a liver clinic at Wollongong Hospital, Wollongong, Australia, were asked to fill out a questionnaire on the functional impact of their fatigue, and a questionnaire on psychological parameters. These were correlated with a history of intravenous drug use, alcohol history, transaminase levels and liver biopsy findings.
RESULTS: Fatigue weakly correlated with the level of fibrosis on the liver biopsy, but strongly correlated with all the psychological domains of depression, anxiety, somatization, interpersonal sensitivity and hostility.
CONCLUSION: The level of fatigue strongly correlated with all the psychological domains, particularly depression, and not with our measures of disease activity.

Entities:  

Mesh:

Year:  2002        PMID: 11966947     DOI: 10.1046/j.1440-1746.2002.02669.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  21 in total

1.  Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.

Authors:  Jeanie C Yoon; Paul K Crane; Paul S Ciechanowski; Robert D Harrington; Mari M Kitahata; Heidi M Crane
Journal:  AIDS Care       Date:  2011-05-23

2.  Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems.

Authors:  Howard Libman; Richard Saitz; David Nunes; Debbie M Cheng; Jessica M Richardson; John Vidaver; Julie K Alperen; Jeffrey H Samet
Journal:  Am J Gastroenterol       Date:  2006-06-16       Impact factor: 10.864

3.  Patients with chronic hepatitis C undergoing watchful waiting: Exploring trajectories of illness uncertainty and fatigue.

Authors:  Donald E Bailey; Julie Barroso; Andrew J Muir; Richard Sloane; Jacqui Richmond; John McHutchison; Keyur Patel; Lawrence Landerman; Merle H Mishel
Journal:  Res Nurs Health       Date:  2010-10       Impact factor: 2.228

4.  Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.

Authors:  Souvik Sarkar; Zhen Jiang; Donna M Evon; Abdus S Wahed; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2012-07-01       Impact factor: 25.083

Review 5.  Fatigue complicating chronic liver disease.

Authors:  E Anthony Jones
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C.

Authors:  Donald E Bailey; Lawrence Landerman; Julie Barroso; Patricia Bixby; Merle H Mishel; Andrew J Muir; Lisa Strickland; Elizabeth Clipp
Journal:  Psychosomatics       Date:  2009 Mar-Apr       Impact factor: 2.386

Review 7.  Fatigue in liver disease: pathophysiology and clinical management.

Authors:  Mark G Swain
Journal:  Can J Gastroenterol       Date:  2006-03       Impact factor: 3.522

8.  Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C.

Authors:  Benjamin J R Stewart; Deborah Turnbull; Antonina A Mikocka-Walus; Hugh A J Harley; Jane M Andrews
Journal:  J Clin Psychol Med Settings       Date:  2013-12

Review 9.  Depression, fatigue and neurocognitive deficits in chronic hepatitis C.

Authors:  Sern Wei Yeoh; Alex C N Holmes; Michael M Saling; Ian P Everall; Amanda J Nicoll
Journal:  Hepatol Int       Date:  2018-06-21       Impact factor: 6.047

10.  Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey.

Authors:  Olivia McKenna; Caitriona Cunningham; Catherine Blake
Journal:  BMC Public Health       Date:  2009-09-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.